Continuation of the etonogestrel implant in women undergoing immediate postabortion placement.

Tessa Madden, David L Eisenberg, Qiuhong Zhao, Christina Buckel, Gina M Secura, Jeffrey F Peipert

Obstetrics and gynecology 2012 Nov

filter terms:

To estimate whether women who receive an immediate postabortion etonogestrel subdermal implant have higher discontinuation rates than women who undergo an interval insertion (insertion not associated with a recent pregnancy). This was a secondary analysis of the Contraceptive CHOICE Project. We compared 12-month continuation rates for the subdermal implant between women undergoing immediate postabortion placement and women who underwent an interval placement. Continuation rates were compared using Kaplan-Meier estimator of survival function and Cox proportional hazard models. Over the study period, 141 women received the implant immediately postabortion and 935 women underwent an interval placement. The 12-month continuation rates were similar: 81.5% among women undergoing immediate postabortion placement and 82.8% among women undergoing interval placement (P=.54). In the survival analysis, women who received an immediate postabortion implant were no more likely to discontinue their method than women who had an interval placement (adjusted hazard ratio 1.04, 95% confidence interval 0.68-1.60). The most common reason given for discontinuation was frequent or irregular bleeding, which was reported by 65.4% of women discontinuing in the immediate postabortion group and 56.7% in the interval group. Women who undergo immediate postabortion placement of the subdermal implant have high rates of continuation that are equivalent to women undergoing interval insertion. Immediate postabortion long-acting reversible contraceptives should be available to women undergoing induced abortion to decrease the risk of repeat unplanned pregnancy. II.

Citation

Tessa Madden, David L Eisenberg, Qiuhong Zhao, Christina Buckel, Gina M Secura, Jeffrey F Peipert. Continuation of the etonogestrel implant in women undergoing immediate postabortion placement. Obstetrics and gynecology. 2012 Nov;120(5):1053-9